Head-to-head · computed 2026-08-11
Henry Meds vs Ivim Health
Henry Meds: Henry Meds sells compounded semaglutide injections at $297 a month ($247 on the six-month and $197 on the twelve-month prepay), oral semaglutide from $249, and tirzepatide only as oral dissolving tablets in a three-month supply — there is no injectable tirzepatide on its menu as of July 2026. Ivim Health: Ivim combines a $75/month membership with tiered medication pricing; its all-in semaglutide figure ($149) is competitive, while tirzepatide lands mid-pack at $278 all-in at the 10 mg basis.
Tirzepatide
| Henry Meds | Ivim Health | |
|---|---|---|
| All-in maintenance | not published | $278/mo |
| Best plan rate | — | $278/mo |
| 12-month total | — | $3,336 |
| Status | Reported · 2026-08-11 | Provider-stated · 2026-08-05 |
The arithmetic
Henry Meds does not publish a rankable maintenance-dose figure for tirzepatide, so no winner can honestly be declared — a start-only price tells you what month one costs, not what the program costs.
Semaglutide
| Henry Meds | Ivim Health | |
|---|---|---|
| All-in maintenance | $297/mo | $149/mo |
| Best plan rate | $197/mo | $149/mo |
| 12-month total | $2,364 | $1,788 |
| Status | Reported · 2026-08-11 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Ivim Health's $149 a month undercuts Henry Meds's $297 by $148 a month at the 2.4 mg/wk maintenance basis — $1,776 across a year. Ivim Health's figure is provider-stated (captured 2026-08-05) and Henry Meds's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Henry Meds's semaglutide ladder runs $297 a month billed monthly, $247 a month on a six-month plan, and $197 a month on a twelve-month plan. Ivim Health's runs $149 a month billed monthly. On the twelve-month basis Ivim Health's $1,788 beats Henry Meds's $2,364 by $576 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
Henry Meds carries no membership fee against Ivim Health's $75 a month — $900 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, Henry Meds is dose-flat — the price survives titration — while Ivim Health's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
Henry Meds
- MembershipNone
- Dose policyMarketing emphasizes a flat fee, but one sourced review reports ~$100/month per tier added above 1 mg semaglutide — confirm the price at your prescribed dose before enrolling
- CommitmentMonthly billing (12 cycles/year) while medication ships in 10–11-week batches; 6- and 12-month prepay tiers
- CancellationMonthly plan cancel-anytime per published terms; prepay tiers reported non-refundable — get the refund formula in writing
- PharmacyTailor Made Compounding (named on dispensed materials; provided pre-order on req
Ivim Health
- Membership$75/mo
- Dose policyTiered by dose on tirzepatide
- CommitmentMonth-to-month
- CancellationCancel anytime
- PharmacyPartner pharmacies
What our desk is watching on each
Henry Meds: Correction on record (2026-08-11): our earlier figures — $179 tirzepatide and $179 semaglutide — were the advertised headline, which independent reviews show applies to liraglutide or the twelve-month prepay, not the flagship products. Checkout-verified semaglutide injection is $297 month-to-month (Tailor Made Compounding named on the dispensed materials), and tirzepatide exists only as oral dissolving tablets capped at 6 mg daily, sold as a $1,047 three-month supply ($891 paid in full) with no month-to-month rate — a different product class from the 10 mg/week injections our rankings price, so Henry is recorded but unrankable on the tirzepatide basis. Structural notes: monthly billing against 10–11-week shipment batches; one source reports ~$100/tier escalation above 1 mg; state coverage sources conflict (every state vs. not available in nine — confirm at intake); 12,000+ Trustpilot reviews alongside an F BBB rating; no FDA warning letter for Henry or parent Adonis Health per an April 21, 2026 database check.
Ivim Health: Dose-tiered tirzepatide means the advertised start price understates maintenance cost; compare on the maintenance column.
Questions people ask
Is Henry Meds or Ivim Health cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Henry Meds vs Ivim Health miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Henry Meds and Ivim Health cost over a full year of semaglutide?
On the plans our database holds, a year of semaglutide runs $2,364 at Henry Meds and $1,788 at Ivim Health — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Henry Meds · Ivim Health. Official sites: Henry Meds ↗ · Ivim Health ↗. Nothing here is medical advice.